NASDAQ: HAOHaoxi Health Technology Ltd Stock
$1.15-0.01 (-0.86%)
Updated Oct 30, 2025
HAO Price
$1.15
Fair Value Price
N/A
Market Cap
$3.33M
52 Week Low
$0.84
52 Week High
$6.79
P/E
0.69x
P/B
0.19x
P/S
0.09x
PEG
0.02x
Dividend Yield
N/A
Revenue
$32.80M
Earnings
$3.88M
Gross Margin
2.8%
Operating Margin
12.78%
Profit Margin
11.8%
Debt to Equity
0.24
Operating Cash Flow
-$3M
Beta
1.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
HAO Overview
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine HAO's potential to beat the market
- HAO doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important HAO news, forecast changes, insider trades & much more!
HAO News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HAO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HAO ($1.15) is trading below its intrinsic value of $34.21, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
HAO is good value based on its earnings relative to its share price (0.69x), compared to the US market average (40.85x)
P/E vs Market Valuation
HAO is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more HAO due diligence checks available for Premium users.
Valuation
HAO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0.69x
Industry
4.58x
Market
40.85x
HAO is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
HAO is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
HAO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.19x
Industry
2.4x
HAO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
HAO price to earnings growth (PEG)
For valuing profitable companies with growth potential
HAO is good value based... subscribe to Premium to read more.
PEG Value Valuation
HAO's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
HAO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
HAO's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$21.6M
Liabilities
$4.2M
Debt to equity
0.24
HAO's short-term assets ($19.60M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HAO's short-term assets ($19.60M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HAO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
HAO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
HAO vs Advertising Agency Stocks
Haoxi Health Technology Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.